Genenta CFO discloses initial option and share holdings
Genenta Science S.p.A.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Genenta Science S.p.A. Chief Financial Officer Richard B. Slansky filed an initial ownership report showing a mix of stock options, ordinary shares and American Depositary Shares. He holds several option grants over ADSs with exercise prices of $4.76, $3.08, $4.36 and $1.48, vesting over multi‑year schedules and expiring between 2032 and 2035. In addition, he directly owns 19,947 ordinary shares and 2,200 ADSs, with each ADS representing one ordinary share.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | American Depositary Shares ("ADSs") | -- | -- | -- |
Footnotes (7)
- F1. Each American Depositary Share represents one ordinary share, no par value, of the Issuer.
- F2. The stock options vest in two parts: options on 22,884 shares vested immediately and became exercisable on July 21, 2022; and options on 104,636 shares vest in equal monthly installments over three-years beginning July 21, 2022.
- F3. The options vest in equal monthly installments over three-years beginning July 1, 2024.
- F4. The stock options vest in equal monthly installments over three-years beginning June 4, 2025.
- F5. The stock options were issued in place of a cash bonus for 2023 and became fully vested and exercisable on June 4, 2025.
- F6. The stock options were issued in place of a cash bonus for 2024 and became fully vested and exercisable on June 4, 2025.
- F7. The stock options vest in equal monthly installments over three-years beginning December 18, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.
